skip navigation

Skip Nav

Ensayos clínicos

Ensayos clínicos

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Patrocinador(es) del estudio: National Institute of Allergy and Infectious Diseases (NIAID)
Números de identificación: NCT00000950, ACTG 309
  • Concluido

Propósito del estudio

To determine variation in serum concentrations of four standard first-line antituberculous agents (isoniazid, rifampin, ethambutol, and pyrazinamide) in HIV-infected patients. To assess pharmacokinetic parameters in this patient population.

Infecciones por el VIH

Criterios de exclusión

    You will not be eligible for this study if you: Have any other disorder or condition which might cause study treatment to be undesirable. Are pregnant.

Centros de estudio/contactos


    Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, 900331079, United States

    Harbor UCLA Med Ctr, Torrance, California, 90502, United States


    University of Miami (Pediatric), Miami, Florida, 33136, United States


    Emory Univ, Atlanta, Georgia, 30308, United States


    Queens Med Ctr, Honolulu, Hawaii, 96816, United States

    Univ of Hawaii, Honolulu, Hawaii, 96816, United States


    Tulane Univ School of Medicine, New Orleans, Louisiana, 70112, United States

New York

    SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, 112032098, United States

    St Vincent's Hosp / Mem Sloan-Kettering Cancer Ctr, New York, New York, 10021, United States

    Mount Sinai Med Ctr, New York, New York, 10029, United States

    Beth Israel Med Ctr, New York, New York, 10003, United States


    MetroHealth Med Ctr, Cleveland, Ohio, 441091998, United States


    Univ of Pennsylvania at Philadelphia, Philadelphia, Pennsylvania, 19104, United States

Actualizado: 13 de octubre del 2004

Volver arriba